Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
NEPTF
Neptune Wellness Solutions
$0.02
$0.00
$0.12
$23K-2.73,696 shs3 shs
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
$0.00
$0.00
$0.21
$36KN/A26,223 shs2,000 shs
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
$0.00
-19.0%
$0.37
$0.00
$4.80
$14KN/A49.49 million shs483.99 million shs
Q BioMed Inc. stock logo
QBIO
Q BioMed
$0.00
$0.00
$0.03
$9K2.2247,605 shsN/A
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
NEPTF
Neptune Wellness Solutions
0.00%0.00%-83.33%+400.00%+499,900.00%
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
0.00%0.00%0.00%0.00%0.00%
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
0.00%-48.48%-99.03%-99.67%+339,900.00%
Q BioMed Inc. stock logo
QBIO
Q BioMed
0.00%0.00%0.00%-66.67%-80.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
NEPTF
Neptune Wellness Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/AN/AN/AN/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/AN/AN/AN/AN/AN/AN/AN/A
Q BioMed Inc. stock logo
QBIO
Q BioMed
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
NEPTF
Neptune Wellness Solutions
2.00
HoldN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
0.00
N/AN/AN/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
0.00
N/AN/AN/A
Q BioMed Inc. stock logo
QBIO
Q BioMed
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
NEPTF
Neptune Wellness Solutions
$52.62M0.00N/AN/A($91.90) per share0.00
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/AN/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/AN/AN/AN/AN/AN/A
Q BioMed Inc. stock logo
QBIO
Q BioMed
$280K0.00N/AN/AN/ANaN
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
NEPTF
Neptune Wellness Solutions
-$60.46M-$106.72N/AN/AN/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/AN/A0.00N/AN/AN/AN/AN/A
Q BioMed Inc. stock logo
QBIO
Q BioMed
-$2.05MN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
NEPTF
Neptune Wellness Solutions
N/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/AN/AN/AN/AN/A
Q BioMed Inc. stock logo
QBIO
Q BioMed
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
NEPTF
Neptune Wellness Solutions
11.72%
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/A
Q BioMed Inc. stock logo
QBIO
Q BioMed
N/A

Insider Ownership

CompanyInsider Ownership
NEPTF
Neptune Wellness Solutions
5.10%
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/A
Q BioMed Inc. stock logo
QBIO
Q BioMed
28.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
NEPTF
Neptune Wellness Solutions
1304.53 million4.30 millionN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
1,70012.95 millionN/ANot Optionable
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/A4.19 millionN/AN/A
Q BioMed Inc. stock logo
QBIO
Q BioMed
391.97 million104.18 millionNot Optionable

Recent News About These Companies

Q BioMed Inc
Orchestra Biomed Reports Q3 2024 Financial Results
A Powerful New Tool for Biomedical Research
Q BioMed Inc QBIO
Biomedical Sciences PhD Program
QBIO Q BioMed Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Neptune Wellness Solutions OTC:NEPTF

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

NephroGenex stock logo

NephroGenex OTCMKTS:NRXGQ

NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.

Polyrizon stock logo

Polyrizon NASDAQ:PLRZ

$0.0034 0.00 (-19.05%)
As of 05/23/2025 04:00 PM Eastern

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Q BioMed stock logo

Q BioMed OTCMKTS:QBIO

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.